+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A two-microRNA signature as a potential biomarker for early gastric cancer

A two-microRNA signature as a potential biomarker for early gastric cancer

Oncology Letters 7(3): 679-684

Gastric cancer (GC) is one of the most common malignant tumors worldwide. No fundamental improvements in the five-year survival rates of patients with GC have been reported due to a low early diagnosis rate. Therefore, the identification of novel biomarkers is urgently required for an early diagnosis of GC. A total of 86 patients were selected for the present study, including 44 patients with early stage GC (T1-T2 according to TNM staging criteria) and 42 normal gastric mucosa samples from non-cancer patients as controls. A total of 18 samples were used for the microRNA (miRNA) microarray experiments, including nine early GC and nine normal gastric mucosa samples. Bioinformatics algorithms, significant analysis of microarray (SAM), top scoring pair (TSP) and statistical receiver operating characteristic curves were used to identify the best signatures. Finally, quantitative PCR was used to validate the candidate biomarkers for early gastric cancer in the test samples (35 cancer and 33 normal samples). Using the SAM algorithm, 14 differential miRNAs were selected as candidate biomarkers. Using the TSP algorithm, hsa-miR-196a and hsa-miR-148a were obtained as a signature to differentiate between the early GC and normal samples. A coincidental result was observed in the test samples. hsa-miR-196a was upregulated and hsa-miR-148a was downregulated in the early GC samples. hsa-miR-196a and hsa-miR-148a have the potential to serve as candidate biomarkers for early GC.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051280747

Download citation: RISBibTeXText

PMID: 24527072

DOI: 10.3892/ol.2014.1797

Related references

A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer. International Journal of Molecular Sciences 19(3), 2018

A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer. Journal of Translational Medicine 11: 73, 2015

Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer. Disease Markers 2015: 435656, 2016

Circulating microRNA-196a is an early gastric cancer biomarker. Oncotarget 9(12): 10317-10323, 2018

A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Biochemical and Biophysical Research Communications 493(3): 1322-1328, 2017

Identification and Validation of Serum MicroRna Biomarker for Early Detection of Gastric Cancer. Gastroenterology 146(5): S-31, 2014

Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer. Oncology Reports 39(3): 1338-1346, 2017

Advance in microRNA as a potential biomarker for early detection of pancreatic cancer. Biomarker Research 4: 20, 2016

Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Letters 316(2): 196-203, 2012

A novel microRna signature associated with cisplatin resistant Nsclc holds both diagnostic and prognostic biomarker potential. Lung Cancer 91: S2-S3, 2016

Expression of microRNA-328 Functions as a Biomarker for Recurrence of Early Gastric Cancer (EGC) After Endoscopic Submucosal Dissection (ESD) by Modulating CD44. Medical Science Monitor 22: 4779-4785, 2017

MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Biomarkers 20(1): 58-63, 2015

Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer. Radiology 281(3): 947-957, 2016

A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. European Journal of Cancer 47(5): 784-791, 2011

A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease. Journal of Alzheimer's Disease 60(4): 1365-1377, 2017